Aug 19, 2024, 10:29
New ELN classification of AML receiving less intense therapies
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about a recent paper by Hartmut Döhner et al. published in Blood Journal.
Authors: Hartmut Döhner, Courtney DiNardo, Andrew Wei, Jianxiang Wang, Agnieszka Wierzbowska et al.
“Just out in Blood Journal – new ELN classification of AML receiving less intense therapies – we discuss this classification in our upcoming Blood Cancer Talks episode with Prof. Andrew Wei.”
Source: Eddie Cliff/X